Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
about
Adjuvant chemotherapy for resected early-stage non-small cell lung cancerRole of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new dataTargeted therapy for localized non-small-cell lung cancer: a reviewSystemic and targeted therapies for early-stage lung cancer50 Years of progress in the systemic therapy of non-small cell lung cancerCirculating Plasma MicroRNAs As Diagnostic Markers for NSCLCTrial on refinement of early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: the TREAT protocolA comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapyThe Lake Wobegon effect: are all cancer patients above average?How individual participant data meta-analyses have influenced trial design, conduct, and analysisTimely initiation of chemotherapy: a systematic literature review of six priority cancers - results and recommendations for clinical practice.Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer.Meta-analysis of time-to-event outcomes from randomized trials using restricted mean survival time: application to individual participant data.Pemetrexed plus carboplatin as adjuvant chemotherapy in patients with curative resected non-squamous non-small cell lung cancer.Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient dataRandomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10.Adjuvant chemotherapy of non-small-cell lung cancer.Role of adjuvant radiotherapy in completely resected non-small-cell lung cancer.Adjuvant Therapy Choices in Patients With Resected Non-Small-Cell Lung Cancer: Correlation of Doctors' Treatment Plans and Relevant Phase III Trial DataEpithelial-mesenchymal transition-associated secretory phenotype predicts survival in lung cancer patients.Advances in adjuvant systemic therapy for non-small-cell lung cancer.A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701).Adjuvant chemotherapy of non-small cell lung cancer.Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?Adjuvant Chemotherapy for the Completely Resected Stage IB Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis.The use of pharmacogenomics for selection of therapy in non-small-cell lung cancerBenefit of adjuvant chemotherapy after resection of stage II (T1-2N1M0) non-small cell lung cancer in elderly patients.Adjuvant therapy for resected non-small cell lung cancerSurvival and risk of adverse events in older patients receiving postoperative adjuvant chemotherapy for resected stages II-IIIA lung cancer: observational cohort study.Are we ready to use biomarkers for staging, prognosis and treatment selection in early-stage non-small-cell lung cancer?Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC).Adjuvant chemotherapy in patients with completely resected non-small cell lung cancerAdjuvant therapy in non-small cell lung cancer: current and future directions.Combined modality treatment of non-small-cell lung cancer.Prognostic factors of resected node-positive lung cancer: location, extent of nodal metastases, and multimodal treatment.Feasibility Of Administering Adjuvant Chemotherapy Of Pemetrexed Followed By Pemetrexed/oxaliplatin Immediately Post-VATS In Patients With Completely Resected NSCLCAdjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research.Adjuvant therapy for resected non-small-cell lung cancer: recent advances, emerging agents, and lingering questions.A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studiesMeta-analysis of postoperative adjuvant chemotherapy without radiotherapy in early stage non-small cell lung cancer
P2860
Q24187439-FE9ADA64-B052-4954-94BC-235A80ED558CQ24633254-0C220834-6101-4251-B9B6-6D3CF4F8C095Q26741441-E05B5F88-72D1-400C-B63B-E649C7D19CD2Q26865490-8C441467-9050-416C-8C81-674C3D360250Q27014978-B7608167-218E-4AE4-B0B5-5DBD56EDACD6Q28073562-AFABF41A-6FDB-4257-8034-B0A081853C80Q28209997-76D59BC2-8760-44E4-BF2E-DE2AAD131714Q28267987-5B619FD7-A1E3-483C-8E17-9988178449B4Q28303620-0B0652BA-4C3A-445B-8BD6-0085AD0FF928Q28607751-50BD80B4-95FF-43E6-9644-049C27AF1A17Q30249083-8F911418-F41C-424F-93BC-33DF3CB7CA35Q30487266-29690DF0-C263-419A-8C2B-E554A4A2A22DQ30976026-87CC039C-7B4C-49CD-B0B2-34D36D335CE1Q33429178-5385CE98-E407-403C-ACA5-23DB442D36B5Q33546241-299A5EC8-26E3-4E6F-A9A9-B08EE525F97FQ33561943-898C9568-55A5-445E-BE8B-26F7470C9F74Q33698361-971575DF-DE21-48C4-B935-1807DD6260FAQ33698439-B753E05D-45FA-4D62-BC84-4ABE99408F9AQ33703679-4323F580-BF19-447D-BAE8-F6AB7BEFE03DQ33705213-2D109839-E958-49C8-B919-A675F8B701ACQ34031225-AFE43BE2-989C-4C96-8282-CD5C43B4527EQ34074425-E63093FD-6427-45CF-B86D-558A626F626EQ34126484-F2D4EA8E-E1DF-4C52-AE61-2177D20C8B5BQ34143336-53FE968A-D9FC-406A-BE0A-FC1825E7257AQ34479081-D2BF08F5-C4C5-4043-82A6-B7F8CE8D31E4Q34657144-D36148B0-56B4-4420-8DB1-B0378C28AFF7Q34978347-35654F54-3529-4D48-AD96-D63C7B10BD52Q35076202-A9D07954-CB36-4AF7-A00F-21D6307731E9Q35104573-2F41CA24-2DE6-4948-A630-AFC443564F2EQ35200402-D7C93CFC-7D6E-40AE-A19F-B82C55AA9238Q35200660-146BCAC8-4D81-4CDF-974E-DF8961FD26EFQ35200745-C687A1C3-83E9-4801-B420-3FA4E623ABE9Q35584223-3DC64450-FA73-4308-8769-E79BB13EE389Q35627621-AAA6AD3A-E0A3-48A7-A072-7183D0437FF3Q35634785-C0F4FD88-050E-4F2C-89D2-42BF3CCF03B4Q35667757-6D2DF179-F40B-4546-8FB6-227F8876C5EAQ35771994-D17B827C-A1DA-41EE-82CC-072194F7C2C2Q35783036-C504D9E1-E44A-4BAB-8628-C5016E78859CQ35803022-5E4415A2-7CB3-4353-80BD-7CB817C8F838Q35934898-AD966B02-A2CE-40CE-B479-7C3A4F4A72CB
P2860
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Randomized study of adjuvant c ...... IA non-small-cell Lung cancer.
@en
type
label
Randomized study of adjuvant c ...... IA non-small-cell Lung cancer.
@en
prefLabel
Randomized study of adjuvant c ...... IA non-small-cell Lung cancer.
@en
P2093
P356
P1476
Randomized study of adjuvant c ...... IA non-small-cell Lung cancer.
@en
P2093
Adjuvant Lung Project Italy/Eu ...... ooperative Group Investigators
Francesco Cognetti
Giorgio V Scagliotti
Giovanni Silvano
Giuseppe Giaccone
Lucio Crinò
Massimo Martelli
Maurizia Clerici
Maurizio Tonato
Roldano Fossati
P304
P356
10.1093/JNCI/DJG059
P407
P577
2003-10-01T00:00:00Z